Le SIDA en Afrique subsaharienne (serveur d'exploration) - Analysis (RSA)

Index « Auteurs » - entrée « Mhairi Maskew »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Mh Hobdell < Mhairi Maskew < Mi-Suk Kang Dufour  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 15.
Ident.Authors (with country if any)Title
000274 (2017) Mhairi Maskew [Afrique du Sud] ; Jacob Bor [Afrique du Sud] ; Cheryl Hendrickson [Afrique du Sud] ; William Macleod [Afrique du Sud] ; Till B Rnighausen [Afrique du Sud] ; Deenan Pillay [Afrique du Sud] ; Ian Sanne [Afrique du Sud] ; Sergio Carmona [Afrique du Sud] ; Wendy Stevens [Afrique du Sud] ; Matthew P. Fox [Afrique du Sud]Imputing HIV treatment start dates from routine laboratory data in South Africa: a validation study.
000447 (2017) Matthew P. Fox [États-Unis] ; Mhairi Maskew [Afrique du Sud] ; Alana T. Brennan [États-Unis] ; Denise Evans [Afrique du Sud] ; Dorina Onoya [Afrique du Sud] ; Given Malete [Afrique du Sud] ; Patrick Macphail [Afrique du Sud] ; Jean Bassett [Afrique du Sud] ; Osman Ebrahim [Afrique du Sud] ; Dikeledi Mabotja [Afrique du Sud] ; Sello Mashamaite [Afrique du Sud] ; Lawrence Long [Afrique du Sud] ; Ian Sanne [Afrique du Sud]Cohort profile: the Right to Care Clinical HIV Cohort, South Africa.
000459 (2017) Eliane Rohner [Suisse] ; Mazvita Sengayi [Afrique du Sud] ; Bridgette Goeieman [Afrique du Sud] ; Pamela Michelow [Afrique du Sud] ; Cynthia Firnhaber [Afrique du Sud] ; Mhairi Maskew [Afrique du Sud] ; Julia Bohlius [Suisse]Cervical cancer risk and impact of Pap-based screening in HIV-positive women on antiretroviral therapy in Johannesburg, South Africa.
000517 (2017) Kate Clouse [États-Unis] ; Constance Mongwenyana [Afrique du Sud] ; Melda Musina [Afrique du Sud] ; Dorah Bokaba [Afrique du Sud] ; Lawrence Long [Afrique du Sud] ; Mhairi Maskew [Afrique du Sud] ; Aima Ahonkhai [États-Unis] ; Matthew P. Fox [Afrique du Sud]Acceptability and feasibility of a financial incentive intervention to improve retention in HIV care among pregnant women in Johannesburg, South Africa.
000604 (2016) Mhairi Maskew [Afrique du Sud] ; Matthew P. Fox [Afrique du Sud, États-Unis] ; Denise Evans [Afrique du Sud] ; Darshini Govindasamy [Afrique du Sud] ; Lise Jamieson [Afrique du Sud] ; Given Malete [Afrique du Sud] ; Constance Mongwenyana [Afrique du Sud] ; Karl Technau [Afrique du Sud]Insights into Adherence among a Cohort of Adolescents Aged 12–20 Years in South Africa: Reported Barriers to Antiretroviral Treatment
000895 (2013) Gilles Wandeler [Afrique du Sud] ; Thomas Gsponer ; Lloyd Mulenga ; Daniela Garone ; Robin Wood ; Mhairi Maskew ; Hans Prozesky ; Christopher Hoffmann ; Jochen Ehmer ; Diana Dickinson ; Mary-Ann Davies ; Matthias Egger ; Olivia KeiserZidovudine impairs immunological recovery on first-line antiretroviral therapy: collaborative analysis of cohort studies in southern Africa.
000908 (2013) Mhairi Maskew [Afrique du Sud] ; Matthew P. Fox ; Gilles Van Cutsem ; Kathryn Chu ; Patrick Macphail ; Andrew Boulle ; Matthias Egger ; For Iedea Southern AfricaTreatment response and mortality among patients starting antiretroviral therapy with and without Kaposi sarcoma: a cohort study.
000A34 (2013) Mhairi Maskew [Afrique du Sud] ; A Patrick Macphail [Afrique du Sud] ; Denise Whitby [États-Unis] ; Matthias Egger [Suisse] ; Matthew P. Fox [Afrique du Sud, États-Unis]Kaposi sarcoma-associated herpesvirus and response to antiretroviral therapy: A prospective study of HIV-infected adults
000A46 (2013) Kate Clouse [Afrique du Sud] ; Audrey Pettifor ; Mhairi Maskew ; Jean Bassett ; Annelies Van Rie ; Cynthia Gay ; Frieda Behets ; Ian Sanne ; Matthew P. FoxInitiating antiretroviral therapy when presenting with higher CD4 cell counts results in reduced loss to follow-up in a resource-limited setting.
000A54 (2013) Michael Schomaker [Afrique du Sud] ; Matthias Egger ; Mhairi Maskew ; Daniela Garone ; Hans Prozesky ; Christopher J. Hoffmann ; Andrew Boulle ; Lukas FennerImmune recovery after starting ART in HIV-infected patients presenting and not presenting with tuberculosis in South Africa.
000C89 (2012) Matthew P. Fox [États-Unis, Afrique du Sud] ; Mhairi Maskew [Afrique du Sud] ; A Patrick Macphail [Afrique du Sud] ; Lawrence Long [Afrique du Sud] ; Alana T. Brennan [États-Unis, Afrique du Sud] ; Daniel Westreich [États-Unis] ; William B. Macleod [États-Unis, Afrique du Sud] ; Pappie Majuba [Afrique du Sud] ; Ian M. Sanne [Afrique du Sud]Cohort Profile: The Themba Lethu Clinical Cohort, Johannesburg, South Africa
000D39 (2012) Matthew P. Fox [États-Unis, Afrique du Sud] ; Kate Shearer [Afrique du Sud] ; Mhairi Maskew [Afrique du Sud] ; William Macleod [États-Unis, Afrique du Sud] ; Pappie Majuba [Afrique du Sud] ; Patrick Macphail [Afrique du Sud] ; Ian Sanne [Afrique du Sud]Treatment outcomes after 7 years of public-sector HIV treatment
000F90 (2010) Babatyi I. Malope-Kgokong [Afrique du Sud] ; Patrick Macphail [Afrique du Sud] ; Georgina Mbisa [États-Unis] ; Edith Ratshikhopha [Afrique du Sud] ; Mhairi Maskew [Afrique du Sud] ; Lara Stein [Afrique du Sud] ; Freddy Sitas [Australie] ; Denise Whitby [États-Unis]Kaposi's Sarcoma Associated-Herpes Virus (KSHV) Seroprevalence in Pregnant Women in South Africa
001194 (2010) Matthew P. Fox [États-Unis, Afrique du Sud] ; Alana Brennan [États-Unis, Afrique du Sud] ; Mhairi Maskew [Afrique du Sud] ; Patrick Macphail [Afrique du Sud] ; Ian Sanne [Afrique du Sud]Using vital registration data to update mortality among patients lost to follow-up from ART programmes: evidence from the Themba Lethu Clinic, South Africa
001238 (2009) Daniel J. Westreich [Afrique du Sud, États-Unis] ; Ian Sanne [Afrique du Sud] ; Mhairi Maskew [Afrique du Sud] ; Babatyi Malope-Kgokong [Afrique du Sud] ; Francesca Conradie [Afrique du Sud] ; Pappie Majuba [Afrique du Sud] ; Michele Jonsson Funk ; Jay S. Kaufman ; Annelies Van Rie [Afrique du Sud] ; Patrick Macphail [Afrique du Sud]Tuberculosis Treatment and Risk of Stavudine Substitution in First-Line Antiretroviral Therapy

List of associated KwdEn.i

Nombre de
documents
Descripteur
6Adult
6Female
6HIV Infections (drug therapy)
6Humans
6Male
5CD4 Lymphocyte Count
4Anti-HIV Agents (therapeutic use)
4HIV Infections (immunology)
4Middle Aged
4South Africa
3Adolescent
3Cohort Studies
3Prognosis
2AIDS
2AIDS-Related Opportunistic Infections (immunology)
2Antiretroviral agent
2Antiviral
2CD4-Positive T-Lymphocytes (immunology)
2Chemotherapy
2HIV Infections (complications)
2HIV Infections (mortality)
2HIV Infections (virology)
2HIV-1 (drug effects)
2Human immunodeficiency virus
2Incidence
2Mortality
2South Africa (epidemiology)
2Sub-Saharan Africa
2Time Factors
2Treatment Outcome
2Viral Load
2Young Adult
1AIDS-Related Opportunistic Infections (complications)
1AIDS-Related Opportunistic Infections (drug therapy)
1AIDS-Related Opportunistic Infections (mortality)
1AIDS-Related Opportunistic Infections (prevention & control)
1Africa, Southern
1Algorithms
1Anemia (chemically induced)
1Anti-HIV Agents (administration & dosage)
1Anti-Retroviral Agents (therapeutic use)
1Antiretroviral Therapy, Highly Active
1Antiretroviral Therapy, Highly Active (methods)
1Clinical Protocols
1Delivery of Health Care (standards)
1Delivery of Health Care (trends)
1Diagnostic Tests, Routine
1Early Detection of Cancer (utilization)
1Educational Status
1Follow-Up Studies
1HIV Seropositivity
1HIV-1 (immunology)
1HIV-1 (isolation & purification)
1Health Resources (supply & distribution)
1Human
1International Cooperation
1Lost to Follow-Up
1Medical Audit
1Multivariate Analysis
1National Health Programs
1Papanicolaou Test
1Pregnancy
1Proportional Hazards Models
1Public sector
1Retrospective Studies
1Risk
1Risk Assessment
1Risk Factors
1Risk factor
1Sarcoma, Kaposi (virology)
1Treatment Failure
1Tropical medicine
1Tuberculosis (complications)
1Tuberculosis (drug therapy)
1Tuberculosis (immunology)
1Tuberculosis, Pulmonary (etiology)
1Tuberculosis, Pulmonary (immunology)
1Tuberculosis, Pulmonary (mortality)
1Tuberculosis, Pulmonary (prevention & control)
1Uterine Cervical Neoplasms (epidemiology)
1Uterine Cervical Neoplasms (prevention & control)
1Uterine Cervical Neoplasms (virology)
1Viral Load (drug effects)
1Zidovudine (adverse effects)
1Zidovudine (therapeutic use)

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/RSA/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/RSA/Analysis/Author.i -k "Mhairi Maskew" 
HfdIndexSelect -h $EXPLOR_AREA/Data/RSA/Analysis/Author.i  \
                -Sk "Mhairi Maskew" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/RSA/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaSubSaharaV1
   |flux=    RSA
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Mhairi Maskew
}}

Wicri

This area was generated with Dilib version V0.6.32.
Data generation: Mon Nov 13 19:31:10 2017. Site generation: Wed Mar 6 19:14:32 2024